Literature DB >> 2400347

Host factors, UV radiation, and risk of uveal melanoma. A case-control study.

J M Seddon1, E S Gragoudas, R J Glynn, K M Egan, D M Albert, P H Blitzer.   

Abstract

Uveal melanoma threatens life, as well as sight. To evaluate the effect of constitutional factors and UV radiation on the risk of uveal melanoma, 197 cases in New England were compared with 385 matched population controls, identified by random-digit dialing, and 337 cases residing within the United States were compared with 800 sibling controls. In the population-based comparison, estimated relative risks (RRs) of uveal melanoma, after adjustment for other factors, were elevated for the following: ancestry from more northern latitudes with a substantially elevated risk for Northern European ancestry (RR, 6.5; 95% confidence interval [CI], 1.9 to 22.4) and more than a twofold risk for British ancestry (RR, 2.4; 95% CI, 1.1 to 5.1), as compared with Southern European or other Mediterranean heritage; light skin color as compared with dark (RR, 3.8; 95% CI, 1.1 to 12.6); and 10 or more cutaneous nevi as compared with none (RR, 2.7; 95% CI, 1.5 to 4.9). There was a statistically significant trend for increasing risk with more northern heritage and more moles. Southern residence (below latitude 40 degrees N) for more than 5 years also increased risk (RR, 2.8; 95% CI, 1.1 to 6.9), as compared with none. In both comparisons, use of sunlamps was a risk determinant (RR, 3.4; 95% CI, 1.1 to 10.3 with random-digit dialed controls and RR, 2.3; 95% CI, 1.2 to 4.3 with sibling controls, comparing occasional or frequent use to never use), as was intense sun exposure (RR, 1.7; 95% CI, 0.9 to 3.0 and RR, 2.1; 95% CI, 1.4 to 3.2, respectively). However, birthplace below latitude 40 degrees N and outdoor work were associated with a lower risk.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2400347     DOI: 10.1001/archopht.1990.01070110090031

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  28 in total

1.  A randomized, controlled trial of varying radiation doses in the treatment of choroidal melanoma.

Authors:  E S Gragoudas
Journal:  Trans Am Ophthalmol Soc       Date:  1998

Review 2.  Risk factors for intraocular melanoma and occupational exposure.

Authors:  J M Lutz; I A Cree; A J Foss
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

3.  Examination of the efficacy of an appearance-focused intervention to reduce UV exposure.

Authors:  Joel J Hillhouse; Rob Turrisi
Journal:  J Behav Med       Date:  2002-08

4.  Epidemiology in practice: case-control studies.

Authors:  S Lewallen; P Courtright
Journal:  Community Eye Health       Date:  1998

Review 5.  The genetics of uveal melanoma: an emerging framework for targeted therapy.

Authors:  J William Harbour
Journal:  Pigment Cell Melanoma Res       Date:  2012-02-13       Impact factor: 4.693

6.  Eye cancer incidence in Singapore.

Authors:  S B Lee; K G Au Eong; S M Saw; T K Chan; H P Lee
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

7.  Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing.

Authors:  Beryl Royer-Bertrand; Matteo Torsello; Donata Rimoldi; Ikram El Zaoui; Katarina Cisarova; Rosanna Pescini-Gobert; Franck Raynaud; Leonidas Zografos; Ann Schalenbourg; Daniel Speiser; Michael Nicolas; Laureen Vallat; Robert Klein; Serge Leyvraz; Giovanni Ciriello; Nicolò Riggi; Alexandre P Moulin; Carlo Rivolta
Journal:  Am J Hum Genet       Date:  2016-10-13       Impact factor: 11.025

8.  Use of sunbeds increases risk of intraocular malignant melanoma.

Authors:  P Dolin
Journal:  BMJ       Date:  1995-08-26

Review 9.  Disparities in Uveal Melanoma: Patient Characteristics.

Authors:  Erin E Nichols; Ann Richmond; Anthony B Daniels
Journal:  Semin Ophthalmol       Date:  2016-04-29       Impact factor: 1.975

Review 10.  Ultraviolet light and ocular diseases.

Authors:  Jason C S Yam; Alvin K H Kwok
Journal:  Int Ophthalmol       Date:  2013-05-31       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.